
24 June 2026Publication
Evolving health product & software risks
Discover how new EU reforms impact liability and recall risks for health products, software and AI - plus practical tips to navigate evolving legal challenges
Healthcare and life science businesses trust us for our in-depth knowledge of this highly-regulated sector. And because our integrated teams deliver exceptional technical expertise and service.
Our global team is dedicated to the full legal scope of healthcare and life sciences, including intellectual property, product liability, competition/antitrust, tax, corporate, employment, investment and finance.
We provide a single source of expert advice across the sector, collaborating closely between practices and across our international network.
That’s why our clients include 18 of the world’s top 20 pharmaceutical companies, global medical device manufacturers, household-name consumer brands, healthcare services businesses and innovative startups
We’re especially active in the world of digital health, combining our experience in both healthcare and technology.
We take pride in delivering exceptional service to our clients. Secondments give our team invaluable experience and insight, and help us to help you plan for future growth. We’re also actively involved with trade associations like EFPIA, and the national associations wherever we work across the world.
The result: comprehensive, consistently high-quality advice. Not just on the details of healthcare legislation, but on commercial strategies for driving your business forward.
If you have any questions, contact a member of the Healthcare and Life Sciences team for assistance:

24 June 2026Publication
Discover how new EU reforms impact liability and recall risks for health products, software and AI - plus practical tips to navigate evolving legal challenges

24 June 2026 Publication
Discover how quantum computing is transforming healthcare and life sciences - explore its breakthrough applications, challenges, and opportunities

24 June 2026 Publication
Discover the essentials of the EU Pharma Package reform: key changes in protection, market access, supply, IP, advertising, digitalisation and policy.

23 June 2026 Publication
Reshaping product development and launch strategies in the HLS sector.

22 June 2026 Publication
Insights from La Matinale 2026: legal, regulatory and supply chain challenges shaping risk and strategy for life sciences companies and insurers.